They found that PRIMA-1 successfully killed undifferentiated thyroid carcinoma cells carrying mutant p53 that were refractory to chemotherapy [84] (Figure 5). This evidence concerns the gene TP53 and thyroid gland undifferentiated (anaplastic) carcinoma.